(61 days)
Not Found
No
The 510(k) summary describes a mechanical device for preventing needlesticks and does not mention any AI or ML components.
No
The device is described as a 'passive needlestick prevention device' and an 'infusion set' used for administering drugs and withdrawing blood; its primary function is not to treat a disease or condition.
No
The device is an infusion set designed for accessing implanted subcutaneous ports for drug administration or blood withdrawal, not for diagnosing conditions.
No
The device description clearly outlines physical components like needles, clips, hubs, base plates, and extension sets, indicating it is a hardware-based medical device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for "implanted subcutaneous port access, used in conjunction with IV administration of chemotherapy and other injectable drugs and/or to withdraw blood." This describes a device used for accessing a patient's circulatory system for therapeutic or diagnostic purposes in vivo (within the body).
- Device Description: The description details a needle and infusion set designed for accessing a port, not for analyzing samples in vitro (outside the body).
- Lack of IVD Characteristics: There is no mention of the device being used to test samples (blood, urine, tissue, etc.) for diagnostic information. The focus is on the physical access and delivery/withdrawal of substances.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
The Surecan™ Safety Huber Needle Infusion Set is a passive needlestick prevention device which is designed to minimize inadvertent needlesticks. The device is intended to provide implanted subcutaneous port access, used in conjunction with IV administration of chemotherapy and other injectable drugs and/or to withdraw blood.
Product codes
FPA, LJT
Device Description
The Surecan™ Safety Huber Needle Infusion Set consists of a standard right angle non-coring Huber needle with a passive safety mechanism clip, hub grip, base plate, extension set with an on-off clamp and a female luer lock connector. The Huber needles range in size from 19 Gauge to 22 Gauge and has an overall needle length ranging from 34 inch to 1-1/2 inch. The Surecan™ Safety Huber Needle Infusion Sets will also be available in two configurations: one with an Ultrasite Valve (previously known as a V2 injection site)/y-site and one without the Ultrasite Valve/y-site. The safety clip mechanism reduces the risk of accidental needlestick injuries by shielding the needle. The safety clip mechanism will activate once the huber needle is pulled from the base plate.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Functional testing was performed to support that there are no new issues of safety or effectiveness raised by the Surecan™ Safety Huber Needle Infusion Set. No sharp injuries or failures of the needlestick prevention feature/safety mechanism occurred.
Key Metrics
Not Found
Predicate Device(s)
K993848, K013394, K982805, K955585
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
8 2002 Jul
5.0 510(k) Summary SUBMITTER: B. Braun Medical Inc. 901 Marcon Boulevard Allentown, PA 18109-9341 (610) 596-2375 Contact: Sheri L. Musgnung, Manager, Regulatory Affairs Surecan™ Safety Huber Needle Infusion Sets DEVICE NAME: COMMON OR USUAL Huber Needle Infusion Sets NAME: DEVICE Class II per Code of Federal Regulations, CLASSIFICATION: Title 21, § 880.5440, Intravascular Administration Sets, product code FPA PREDICATE DEVICE: Millennium Medical Distribution Inc. Millennium Huber Plus Safety Infusion Set, K993848 Specialized Health Products, Inc. Liftloc™ Safety Infusion Set, K013394 B. Braun Medical Inc.'s Introcan® Safety™ IV Catheter, K982805 V2 Injection Site (Ultrasite®) valve, K955585 DESCRIPTION: The Surecan™ Safety Huber Needle Infusion Set consists of a standard right angle non-coring Huber needle with a passive safety mechanism clip, hub grip, base plate, extension set with an on-off clamp and a female luer lock connector. The Huber needles range in size from 19 Gauge to 22 Gauge and has an overall needle length ranging from 34 inch to 1-1/2 inch. The Surecan™ Safety Huber Needle Infusion Sets will also be available in two configurations: one with an Ultrasite Valve (previously known as a V2 injection site)/y-site and
one without the Ultrasite Valve/y-site.
1
The safety clip mechanism reduces the risk of accidental needlestick injuries by shielding the needle. The safety clip mechanism will activate once the huber needle is pulled from the base plate.
INTENDED USE:
The Surecan™ Safety Huber Needle Infusion Set is a passive needlestick prevention device which is designed to minimize inadvertent needlesticks. The device is intended to to provide implanted subcutaneous port access, used in conjunction with IV administration of chemotherapy and other injectable drugs and/or to withdraw blood.
SUBSTANTIAL EQUIVALENCE:
The Surecan™ Safety Huber Needle Infusion Set is similar in indications for use, has a safety feature to help minimize accidental needlestick injuries, and has a similar design to Millennium Medical Distribution, Inc. Millennium Huber Plus Safety Infusion Set, K993848 and to Specialized Health Products, Inc. Liftloc™ Safety Infusion Set, K013394. The Ultrasite® Valve and the safety clip mechanism that is a component of the Surecan™ Safety Huber Needle Infusion Set are identical to the previously B. Braun Medical Inc.'s premarket notifications, K955585 and K982085. Functional testing was performed to support that there are no new issues of safety or effectiveness raised by the Surecan™ Safety Huber Needle Infusion Set. No sharp injuries or failures of the needlestick prevention feature/safety mechanism occurred.
000013
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around it. Inside the circle is a stylized image of three human figures, possibly representing health and well-being.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL
8 2002
Ms. Sheri L. Masgnung Regulatory Affairs Manager B. Braun Medical, Incorporated Manufacturing Division 901 Marcon Boulevard Allentown, Pennsylvania 18109
Re: K021488
Trade/Device Name: Surecan® Safety Huber Needle Infusion Sets Regulation Number: 880.5965 and 880.5440 Regulation Name: Subcutaneous, Implanted, Intravascular Infusion Port and Catheter Regulatory Class: II Product Code: LJT and FPA Dated: May 7, 2002 Received: May 8, 2002
Dear Ms. Masgnung:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Les Autotour
Timoth Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
4
Indications for Use Statement
Page _________________________________________________________________________________________________________________________________________________________________________
510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Surecan™ Safety Huber Needle Infusion Sets Device Name:
Indications For Use:
The Surecan™ Safety Huber Needle Infusion Set is a passive needlestick prevention device which is designed to minimize inadvertent needlesticks. The device is intended to provide implanted subcutaneous port access, used in conjunction with IV administration of chemotherapy and other injectable drugs and/or to withdraw blood.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use Use Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________
Pelagia Cissente
(Division Sign-Off) Division of Dental, Infect Division of Storital De 510(k) Number -
000010